Using the U87MG glioma cell line, we found that IDO1/TDO accounted for the production of Kyn, which activated AhR to promote cell motility via the Kyn–AhR–AQP4 signaling pathway and modulated the cell area and cytoskeleton. The gene discussed is AQP4; the disease is central nervous system cancer.